[HTML][HTML] CAR-T cell therapy in hematological malignancies: current opportunities and challenges
X Zhang, L Zhu, H Zhang, S Chen, Y Xiao - Frontiers in immunology, 2022 - frontiersin.org
Chimeric antigen receptor T (CAR-T) cell therapy represents a major breakthrough in cancer
treatment, and it has achieved unprecedented success in hematological malignancies …
treatment, and it has achieved unprecedented success in hematological malignancies …
[HTML][HTML] Biological drivers of clinical phenotype in myelofibrosis
J Mascarenhas, HFE Gleitz, HT Chifotides… - Leukemia, 2023 - nature.com
Myelofibrosis (MF) is a myeloproliferative disorder that exhibits considerable biological and
clinical heterogeneity. At the two ends of the disease spectrum are the myelodepletive or …
clinical heterogeneity. At the two ends of the disease spectrum are the myelodepletive or …
[HTML][HTML] Iron dysregulation and inflammatory stress erythropoiesis associates with long-term outcome of COVID-19
Persistent symptoms following SARS-CoV-2 infection are increasingly reported, although
the drivers of post-acute sequelae (PASC) of COVID-19 are unclear. Here we assessed 214 …
the drivers of post-acute sequelae (PASC) of COVID-19 are unclear. Here we assessed 214 …
[HTML][HTML] Chromatin-associated molecular patterns (CAMPs) in sepsis
Several molecular patterns have been identified that recognize pattern recognition
receptors. Pathogen-associated molecular patterns (PAMPs) and damage-associated …
receptors. Pathogen-associated molecular patterns (PAMPs) and damage-associated …
[HTML][HTML] Pathophysiology of red blood cell dysfunction in diabetes and its complications
A Williams, R Bissinger, H Shamaa, S Patel, L Bourne… - Pathophysiology, 2023 - mdpi.com
Diabetes Mellitus (DM) is a complex metabolic disorder associated with multiple
microvascular complications leading to nephropathy, retinopathy, and neuropathy. Mounting …
microvascular complications leading to nephropathy, retinopathy, and neuropathy. Mounting …
Erythroblastic islands foster granulopoiesis in parallel to terminal erythropoiesis
The erythroblastic island (EBI), composed of a central macrophage surrounded by maturing
erythroblasts, is the erythroid precursor niche. Despite numerous studies, its precise …
erythroblasts, is the erythroid precursor niche. Despite numerous studies, its precise …
[HTML][HTML] Normal and dysregulated crosstalk between iron metabolism and erythropoiesis
Y Ginzburg, X An, S Rivella, A Goldfarb - Elife, 2023 - elifesciences.org
Erythroblasts possess unique characteristics as they undergo differentiation from
hematopoietic stem cells. During terminal erythropoiesis, these cells incorporate large …
hematopoietic stem cells. During terminal erythropoiesis, these cells incorporate large …
Immune dysregulation and potential targeted therapy in myelodysplastic syndrome
X Zhang, X Yang, L Ma, Y Zhang… - Therapeutic Advances in …, 2023 - journals.sagepub.com
Myelodysplastic syndrome (MDS) is a heterogeneous group of clonal hematological
diseases and a high risk for transformation to acute myeloid leukemia (AML). The …
diseases and a high risk for transformation to acute myeloid leukemia (AML). The …
Human TLR8 induces inflammatory bone marrow erythromyeloblastic islands and anemia in SLE-prone mice
Anemia commonly occurs in systemic lupus erythematosus, a disease characterized by
innate immune activation by nucleic acids. Overactivation of cytoplasmic sensors by self …
innate immune activation by nucleic acids. Overactivation of cytoplasmic sensors by self …
[HTML][HTML] Neuronal nitric oxide synthase is required for erythropoietin stimulated erythropoiesis in mice
J Lee, S Dey, PK Rajvanshi, RK Merling… - Frontiers in Cell and …, 2023 - frontiersin.org
Introduction: Erythropoietin (EPO), produced in the kidney in a hypoxia responsive manner,
is required for red blood cell production. In non-erythroid tissue, EPO increases endothelial …
is required for red blood cell production. In non-erythroid tissue, EPO increases endothelial …